Diabetes researchers from across the world shared their latest breakthroughs at this year’s annual European Association for the Study of Diabetes (EASD) conference. Here we share a few of the conference highlights.
Genetic engineering to develop new type 2 treatments
People living with type 2 diabetes usually have insulin resistance. This means that their bodies can’t use the insulin they produce properly, so cells can’t remove glucose, or sugar, from the blood as easily. Normally this is treated with tablets or by eating well and getting active, but these don’t work for everyone. So scientists have been looking for different ways to help people with insulin resistance.
Read more at: https://www.diabetes.org.uk/about_us/news/easd-2022-highlights
